A method is described for the quantitation of serum antibody to type-specific pneumococcal polysaccharide. The method uses highly purified pneumococcal polysaccharide coated onto human 0+ red blood cells by the chromic chloride technique. Each of 14 pneumococcal polysaccharide types was individually coated onto red blood cells and used to determine the antibody response following primary immunization. The method was found to be sensitive, detecting antibody titer increases of several hundred to a thousand-fold. The presence of high preimmunization antibody titers did not obscure the detection of antibody titer increases. The method detected antibody of both the immunoglobulin M and immunoglobulin G class when quantitated after ultracentrifugation and sucrose density gradient separation. By using serum samples obtained from volunteers immunized with a single pneumococcal polysaccharide, the method was standardized resulting in an ability to compare samples taken at different times and obtained from different sources. The method appears to be simple, reproducible, and inexpensive and can be utilized to determine the antibody response following immunization in large population studies.
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Despite the availability of effective antibiotic treatment for pneumococcal disease, a significant morbidity and mortality continues to be observed following pneumococcal infection. This appears to be particularly true in compromised hosts such as patients with Sickle cell disease, young children following splenectomy, individuals on immunosuppressive therapy, and the aged (2, 10) . Pneumococcal infection also appears to be a primary cause of bacterial otitis media in infants and children (5) . Other problems related to pneumococcal infection have emerged. Recently, relative resistance of pneumococcal organisms to penicillin has been described (4) . The extent of these problems has led to renewed interest in the prevention of pneumococcal disease, and studies have been undertaken to determine the effect of immunizing individuals with purified pneumococcal polysaccharide (PPS) vaccines. An important part of these studies is the ability to measure the immunogenicity of the antigen utilized.
Methods utilized to measure antibody response must be sensitive, reproducible, inexpensive, and have the ability to quantitate large numbers of serum samples. In this paper we describe a method which fulfills these criteria and which appears to have widespread application for use in immunization programs involving the administration of pneumococcal polysaccharides. For proper coating of the red cells with antigen, the addition of reagents in the following sequence was found to be essential: (i) 50 jliters of washed, packed red blood cells were pipetted into a 6-ml tube (12 by 75 mm), (ii) 100 jliters of pneumococcal polysaccharide antigen solution (2.0 mg/ml in normal saline) was then added while gently shaking the tube, (iii) 100 Mliters of a dilution of the stock solution of chromic chloride was added and the tube was shaken by hand for 4 min. The cells were then washed three times in 5-ml volumes of normal saline followed by spinning at 3,200 rev/min in the Adams Serofuge for 30 sec. After the last wash, the cells were suspended in 3.0 ml of a solution of 0.01 M phosphate-buffered saline (pH 7.2) containing bovine serum albumin and dextrose (100 ml of phosphate-buffered saline, 1.6 ml of 30% bovine serum albumin, and 100 mg of dextrose; designated as solution 1). This coated cell suspension could be kept for 5 days at 5 C giving reproducible results when diluted in the ratio of 0.5 ml of cell suspension plus 3.0 ml of solution I.
MATERIALS AND METHODS
For large assays, where the serum samples to be tested against one PPS type exceeded 40, the Autotiter III (Canalco, Inc., Rockville, Md.) was employed.
This machine automatically adds 25 ,liters of diluting solution (solution II: 0.01 M phosphate-buffered saline, pH 7.2, containing 50 liters of Tween 80/100 ml, 1.0 mg of polyvinylpropylene [PVP] per 100 ml, and 1.5 ml of 30% bovine serum albumin per 100 ml) to all but the first row of wells of the Canalco-supplied plates ("Autotray," clear, V bottom). The Autotiter III then serially dilutes the previously applied serum samples in the first row of wells, adds uncoated red cells to the first row of wells as a control for antibodies against blood group substances, and then adds coated red cells to the remaining 14 rows of 8 wells. The plates were sealed with tape, agitated for 200 rev on a TekTator (Scientific Products no. R4318), and incubated in a horizontal position for 2 hr at room temperature. The plates were then centrifuged in special centrifuge carriers (Canalco, Inc., Rockville, Md.) at 1,000 rev/min for 3 min (International model PR-J). After centrifugation, the plates were elevated at a 600 angle for 10 min, and the "run down" pattern was read (9) . The highest titer that resulted in agglutination (no run down) was recorded as the end titer.
The Canalco microtiter plates were used directly as supplied, without previous washing. The serum samples were applied with a 50-Mliter Eppendorf pipette with disposable tips. The same application could be made 24 hr preceding the run (in this case, the plates were briefly agitated just before starting the run on the following day). As many as 50 plates (400 serum samples) could be prepared and stored at 5 C overnight.
The microtiter dilutors on the Autotiter III are spun in a running water bath before starting each new plate. An electric flaming device on the machine is bypassed because of the probability of carbon flecks interfering with the run down pattern. The dilutors are periodically placed in a Mettler ultrasonic bath for 10 min for thorough cleaning.
In assays utilizing the Autotiter III, 0.025 ml of washed, packed red blood cells were coated with the specific antigen with the same ratio of cells-antigenchromic chloride as noted above. That is, 0.025 ml of washed, packed red cells, 0.50 ml of specific PPS antigen at 2.0 mg/ml of normal saline, and 0.50 ml of the appropriate dilution of stock chromic chloride. In this way, 105 ml of the coated red cells diluted in solution I could be prepared. Voi- 24, 1972 pressed as the fold change with a negative sign.
None were recorded in this series. Antibody titer increase was expressed as fold increase to reduce variations in expression of results. The highest titers which could be read without further dilution of sera was 1: 8, 192 .
The results in Table 3 show the antibody response of patients of different ages to a monovalent vaccine (Eli Lilly pneumococcal polysaccharide type I, 0.05 mg, subcutaneously) after a 2-week postimmunization period. Table 4 shows the antibody response of four patients immunized against two different monovalent types of pneumococcal polysaccharide (Eli Lilly pneumococcal polysaccharide type III and type VIII, 0.05 mg of each, given subcutaneously) with postimmunization samples drawn at 2 weeks, 6 months, and 1 year. Antibody titer increases persisted up to 1 year following immunization without additional known antigenic stimulation. Table 5 illustrates the results of antibody determination performed on selected sera following sucrose density ultracentrifugation. Antibody of both the IgG and IgM class was detected in significant titers 5 days and 7 days Table 1) .
The method detected antibody titer increases in patients with no preimmunization titers and high preimmunization titers ( Table 2 ). The antibody response of adults as well as infants and children was significant and did not appear to be related to the presence or absence of a preimmunization titer (Table 3 ). Significant antibody titers (expressed as fold increase compared to the original preimmunization sample) were found up to 1 year after immunization ( Table 4) .
Antibody of both the IgG and IgM class was detected. Table 5 shows antibody titers on sera following ultracentrifugation demonstrating antibody in both IgG and IgM fractions. Table 6 demonstrates the presence of significant antibody to pneumococcal polysaccharide in the cord blood of two infants; one without serum IgM and one without serum IgA. Since passive transfer of maternal antibody to the infant resides in IgG, these results offer further confirmatory evidence that the indirect hemagglutination method detects antibody of both the IgG and IgM class. The detection of antibody following 2-mercaptoethanolamine inactivation also confirms these observations. Standardization of the method was accomplished by several means. Normal individuals were immunized with a single pneumococcal polysaccharide. A unit of blood was obtained 14 days later, and the serum was fractionated into 1-ml samples which were subsequently frozen and stored. Each run of antibody titers subsequently included a standard and the results of the antibody titer compared with previous runs.
Comparison of results was made by calculating fold increase rather than actual antibody titer. For example, a patient with a preimmunization titer of 1:8 and a postimmunization titer of 1: 64 and another patient with a preimmunization titer of 1: 256 and a postimmunization titer of 1: 2,048 would both have a fold increase of 8. It was felt that the use of fold increase would also decrease errors in comparison due to minor variations in the sensitivity of the assay. If, for example, the previous illustration represented different results obtained on the same patient run on different days, then the final result would be identical, e.g., fold increase of 8, even though the actual titers varied.
Difficulties involving consistent coating were overcome by using the same donor of red blood cells. Blood was drawn each Friday and then used during the following week.
Large numbers of serum samples could be quantitated by using a semi-automated hemagglutination device (Autotiter IlI, Canalco Inc.). To avoid diluting serum samples, the sensitivity of the method was reduced so that the highest positive titer was less than 1:8,192 . This was accomplished by increasing the coated red blood cell concentration. Reduction in sensitivity did not affect results when expressed as fold increase.
Repeated freezing and thawing or prolonged storage of serum samples at -20 C, or both, did not significantly alter hemagglutination titers.
